2nd Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Income
$180,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to drug pricing proposals including the Inflation Reduction Act (PL 117-169). Rx oversight issues. PAHPA reauthorization and drug pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA ABRAM | — |
| LOUIS AGNELLO | — |
| RYAN ELLIS | — |
| GEOFF VERHOFF | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.